Objectives: Escherichia coli ST131 is a globally disseminated MDR clone originally identified due to its association with the bla CTX-M-15 gene encoding an ESBL. It is thus assumed that bla CTX-M-15 is the major determinant for resistance to b-lactam antibiotics in this clone. The complete sequence of EC958, a reference strain for E. coli ST131, revealed that it contains a chromosomally located bla CMY-23 gene with an upstream ISEcp1 element as well as several additional plasmid-encoded b-lactamase genes. Here, we examined the genetic context of the bla CMY-23 element in EC958 and other E. coli ST131 strains and investigated the contribution of bla CMY-23 to EC958 resistance to a range of b-lactam antibiotics.
Introduction
Escherichia coli ST131 is a globally disseminated MDR clone originally identified due to its close association with the spread of the bla CTX-M-15 ESBL gene. 1 -3 Two studies have recently reported the global epidemiology of E. coli ST131 using WGS, and revealed the bla CTX-M-15 allele is highly prevalent within a fluoroquinolone-resistant FimH30 (H30) ST131 sublineage (referred to as clade C2 4 or H30-Rx
5
). We have characterized and completely sequenced the reference ST131 strain EC958. 6 E. coli EC958 is a urinary tract infection (UTI)-derived fluoroquinolone-resistant, fimH30 E. coli ST131 strain. 7 The strain is a representative member of the UK epidemic strain A, one of the major pathogenic lineages causing UTI across the UK, 3 and belongs to the recently defined phylogenetic C2 lineage of ST131. 4 EC958 contains a large multidrug resistance plasmid (pEC958; HG941719) that harbours a copy of bla CTX-M-15 gene. The bla CTX-M-15 gene has always been seen with an upstream ISEcp1 insertion element. 8 ISEcp1 contains a well-described outward-facing promoter that drives the transcription of the downstream bla CTX-M-15 gene, 9 and this transposition unit has been identified on multiple plasmids characterized from ST131 strains. 10 Several different insertions of IS26 in the region upstream of bla CTX-M-15 have been reported, including the insertion at 24 bp upstream of the right inverted repeat (IRR) of ISEcp1, which results in reduced resistance to cephalosporins. 10 This particular insertion was first identified in UK epidemic strain A isolates and was also found on plasmid pEC958 from the E. coli ST131 strain EC958.
In addition to the production of ESBLs, resistance to thirdgeneration cephalosporins can also be mediated by chromosomal and plasmid-encoded AmpC (or class C) b-lactamases. 11 The plasmid-encoded bla CMY-1 gene and its variants are related to chromosomal AmpC enzymes from Aeromonas spp., while bla CMY-2 and its variants are related to AmpC b-lactamases from Citrobacter freundii.
11 bla CMY-2 gene is the most frequently reported plasmid-mediated AmpC b-lactamase worldwide; it confers resistance to cephamycins (cefoxitin and cefotetan) and oxyimino-cephalosporins (cefotaxime and ceftazidime) and is poorly inhibited by b-lactamase inhibitors, including clavulanate, sulbactam and tazobactam. 12 Several studies have reported the identification of bla CMY-2 in E. coli ST131. 13, 14 In addition, a variant of bla CMY-2 , named bla CMY-23 , has been identified in several E. coli ST131 isolates belonging to the UK epidemic E. coli strain A. 15 The bla CMY-2 and bla CMY-23 genes differ by a single nucleotide, which results in a Glu239Gly amino acid substitution in CMY-23.
A bla CMY-23 gene accompanied by an upstream ISEcp1 insertion element was found inserted in the chromosome of EC958. This led us to hypothesize that CMY-23, instead of CTX-M-15, is the b-lactamase responsible for cephalosporin resistance in EC958. Here, we investigated the contribution of bla CMY-23 to EC958 resistance to a range of b-lactam antibiotics, and demonstrated that it is the primary mediator of resistance to third-generation cephalosporins and cephamycins.
Materials and methods

Bacterial strains and growth conditions
The strains used in this study are listed in Table S1 (available as Supplementary data at JAC Online). All E. coli strains were routinely cultured at 378C on solid or in liquid Lysogeny Broth (LB) medium supplemented with an appropriate antibiotic: chloramphenicol (30 mg/L), gentamicin (20 mg/L) or ampicillin (100 mg/L).
Antimicrobial susceptibility testing
The MICs of b-lactam antibiotics were determined by Etest (bioMé rieux Australia) on Mueller -Hinton agar at 378C using EUCAST breakpoints (http://www.eucast.org/clinical breakpoints/).
Molecular methods
Genomic DNA preparation and DNA sequencing were performed as described previously. 16 Oligonucleotides used in this study are listed in Table S2 . Plasmids pQF50::ISEcp1 and pQF50::IS5+ISEcp1 were created by PCR amplification of the fragments indicated in Table S1 and cloned into pQF50 via BamHI-HindIII digestion. The resulting plasmids were electroporated into E. coli TOP10. Mutants containing deletions in the bla CMY-23 gene and IS5 were constructed by l-Red-mediated recombination as previously described.
7 b-Galactosidase assays were performed as previously described. 16 
Results and discussion
The bla CMY-23 gene is located on the chromosome of E. coli EC958 E. coli EC958 contains a chromosomally encoded bla CMY-23 gene (EC958_4781). Closer inspection of its genomic context suggests an insertion event of a 4277 bp mobile element (nucleotides 4 937 433 -4 941 709, including ISEcp1, IS5 and bla CMY-23 ) into the betU gene (encodes a betaine uptake system) within the GI-leuX genomic island, creating 5 bp direct repeats (DRs) of TATAT ( Figure 1a ). This insertion was not found in the E. coli ST131 strain JJ1886 (CP006784), which harbours two tandem copies of the GI-leuX island ( Figure S1 ). ISEcp1 is known to mediate the transposition of its downstream genes using an imperfect IRR (IRR ′ ). 17 
Prevalence of ISEcp1-bla CMY-23
The bla CMY-23 gene (DQ438952) was first reported from isolates within the UK epidemic strain A, which was later shown to be part of the E. coli ST131 lineage. 15 A second bla CMY-23 sequence has been reported from Salmonella enterica serovar Senftenberg (DQ463751). However, neither of these entries includes information about the genomic context nor location of the bla CMY-23 gene.
Analysis of a global collection of previously sequenced ST131 strains 4 identified five clade C2 strains (S30EC, accession number ERR161246; S39EC, accession number ERR161248; S43EC, accession number ERR161249; S47EC, accession number ERR161250; and S53EC, accession number ERR161251) that possess the bla CMY-23 gene. Further PCR and sequencing of S30EC, S39EC and S43EC confirmed that they contain an identical ISEcp1-IS5-bla CMY-23 sequence inserted at the same location on the chromosome as in EC958 (Figure 1b) . Of note, EC958 and these five strains were all isolated from the same hospital in the UK (from 2004 to 2007) where the first bla CMY-23 positive strain was reported. 15 We also identified one strain (S79EC, accession number ERR161305) from the ST131 clade A phylogeny that contained the bla CMY-2 gene within a transposition unit identical to that found in IncI1 plasmids pSTM709 (HG428759) and pCVM29188_101 (CP001121). This unit lacks IS5, has a longer region downstream of ISEcp1 (2253 bp compared with 1422 bp) and based on its flanking genes may be located on a plasmid in S79EC (Figure 1b) .
The bla CMY-23 gene is the major contributor to EC958 resistance to third-generation cephalosporins EC958 harbours several genes that could contribute to its resistance to b-lactam antibiotics, including bla TEM-1 , bla OXA-1 , bla CTX-M-15 , bla CMY-23 and the chromosomal ampC gene. To specifically demonstrate the contribution of bla CMY-23 to EC958 resistance, we mutated the bla CMY-23 gene using l-Red-mediated homologous recombination. The resultant strain, designated EC958Dbla CMY-23 , was then tested in parallel with WT EC958 against a panel of b-lactam antibiotics. Despite the presence of pEC958 (which harbours bla TEM-1 , bla OXA-1 and bla CTX-M-15 ), EC958Dbla CMY-23 displayed significantly enhanced susceptibility to cefoxitin, cefotaxime and ceftazidime (8-16-fold reduction in MIC; Table 1 ) compared with WT EC958. Taken together, our data confirm that the bla CMY-23 gene is the main determinant that mediates resistance to secondand third-generation cephalosporins in EC958.
bla expression is induced by cefotaxime, but not affected by IS5
We used qRT -PCR to evaluate the transcription of the five b-lactamase genes in EC958. Our results showed that bla Phan et al.
is the most strongly transcribed b-lactamase gene in EC958 (8-fold higher than the reference gene recA; Figure S2 ). In contrast bla CTX-M-15 is transcribed weakest (12-fold lower than recA). These data are consistent with the mutant data reported above, and in accordance with previous publications that show ISEcp1 contains a functional promoter that drives the transcription of downstream genes including CMY variants. 9, 18 To investigate the activity of the bla CMY-23 promoter in EC958, we cloned the region corresponding to the end of ISEcp1 in front of the promoterless lacZ gene in plasmid pQF50 to generate plasmid pQF50::ISEcp1. A 2-fold increase in b-galactosidase activity was observed for E. coli TOP10 harbouring pQF50::ISEcp1 grown in LB medium containing cefotaxime compared with LB medium alone (P, 0.0001) (Figure 1d) . No b-galactosidase Chromosomal bla CMY-23 in E. coli ST131 JAC activity was detected in the vector control strain grown under the same conditions. IS5 has been shown to alter transcription by enhancing the activity of a promoter downstream of its site of insertion. 19, 20 Thus, we investigated whether the IS5 element located within ISEcp1 affects expression of the bla CMY-23 gene using two complementary approaches. First, we cloned the ISEcp1 promoter region together with the upstream IS5 in front of the promoterless lacZ gene in plasmid pQF50 to generate plasmid pQF50::IS5+ISEcp1 and showed that there was no difference in the b-galactosidase activity between TOP10(pQF50::IS5+ISEcp1) and TOP10(pQF50::ISEcp1) (Figure 1d ). Second, we deleted the IS5 element using l-Red-mediated homologous recombination. The resultant strain, designated EC958DIS5, did not show any difference in antibiotic resistance profile from that of WT EC958 (Table 1 ). These results demonstrate that the bla CMY-23 promoter provided by ISEcp1 is functional and can be induced by cefotaxime.
Conclusions
bla CTX-M-15 is considered to be the main determinant for resistance to third-generation cephalosporins in E. coli ST131. Here, we showed that in EC958, which contains a plasmid-located bla CTX-M-15 gene, cephalosporin resistance is conferred by a chromosomal bla CMY-23 gene that encodes an AmpC type b-lactamase. We also showed that the bla CMY-23 in EC958 is strongly transcribed from a promoter located within ISEcp1 that can be induced by cefotaxime. 
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